SKF 81297 hydrobromide,
67287-39-2,
(+/-)-6-Chloro-PB hydrobromide,
CHEMBL553503,
SR-01000075403,
EU-0101162,
MLS000860018,
(y)-6-Chloro-PB hydrobromide,
(?)-6-Chloro-PB hydrobromide,
DTXSID6042604,
SCHEMBL11253953,
Tox21_501162,
BN0485,
AKOS024456604,
CCG-222466,
LP01162,
NCGC00094421-01,
NCGC00261847-01,
LS-27996,
SMR000326876,
NCG-C00094421-01,
S-143,
( inverted question mark)-6-Chloro-PB hydrobromide,
( inverted question mark)-SKF-81297 hydrobromide,
SR-01000075403-1,
SR-01000075403-3,
( inverted exclamation markA)-SKF-81297 hydrobromide,
( inverted exclamation markA)-6-Chloro-PB hydrobromide,
( inverted exclamation markA)-SKF 81297 (hydrobromide),
(+/-)-6-Chloro-PB hydrobromide, >=98% (HPLC), solid,
(+/-)-6-Chloro-2,3,4,5-tetrahydro-1-phenyl-1H-3-benzazepine hydrobromide,
(+)-6-chloro-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-[1h]-3-benzazepine hydrobromide,
(+/-)-6-Chloro-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro[1H]-3-benzazepine,
6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine-7,8-diol hydrobromide,
6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol hydrobromide,
( inverted exclamation markA)-6-Chloro-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrobromide,
R(+)-6-CHLORO-7,8-DIHYDROXY-1-PHENYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINE HYDROBROMIDE,
UNII-9GBP09E08K,
Skf-81297,
C16-H16-Cl-N-O2,
R(+)-SKF-81297 hydrobromide,
SK&F 81297,
CID11957706,
71636-61-8,
1H-3-Benzazepine-7,8-diol,6-chloro-2,3,4,5-tetrahydro-1-phenyl-,
6-Chloro-2,3,4,5-tetrahydro-1-phenyl-1H-3-benzazepine-7,8-diol,
(R)-6-chloro-1-phenyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine-7,8-diol hydrobromide,
-6-CHLORO-7,8-DIHYDROXY-1-PHENYL-2,3,4,5-TETRAHYDRO-1H-3-BENZAZEPINEHYDROBROMIDE,
253446-15-0,